180 related articles for article (PubMed ID: 28257042)
1. The PRR11-SKA2 Bidirectional Transcription Unit Is Negatively Regulated by p53 through NF-Y in Lung Cancer Cells.
Wang Y; Weng H; Zhang Y; Long Y; Li Y; Niu Y; Song F; Bu Y
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28257042
[TBL] [Abstract][Full Text] [Related]
2. The gene pair PRR11 and SKA2 shares a NF-Y-regulated bidirectional promoter and contributes to lung cancer development.
Wang Y; Zhang Y; Zhang C; Weng H; Li Y; Cai W; Xie M; Long Y; Ai Q; Liu Z; Du G; Wang S; Niu Y; Song F; Ozaki T; Bu Y
Biochim Biophys Acta; 2015 Sep; 1849(9):1133-44. PubMed ID: 26162986
[TBL] [Abstract][Full Text] [Related]
3. PRR11 and SKA2 gene pair is overexpressed and regulated by p53 in breast cancer.
Wang Y; Zhang C; Mai L; Niu Y; Wang Y; Bu Y
BMB Rep; 2019 Feb; 52(2):157-162. PubMed ID: 30760381
[TBL] [Abstract][Full Text] [Related]
4. HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas.
Sun Y; Xu D; Zhang C; Wang Y; Zhang L; Qiao D; Bu Y; Zhang Y
Genes (Basel); 2021 Jan; 12(1):. PubMed ID: 33477943
[TBL] [Abstract][Full Text] [Related]
5. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
[TBL] [Abstract][Full Text] [Related]
6. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
[TBL] [Abstract][Full Text] [Related]
7. PRR11 and SKA2 promote the proliferation, migration and invasion of esophageal carcinoma cells.
Chen J; Yang HM; Zhou HC; Peng RR; Niu ZX; Kang CY
Oncol Lett; 2020 Jul; 20(1):639-646. PubMed ID: 32565988
[TBL] [Abstract][Full Text] [Related]
8. Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters.
Imbriano C; Gurtner A; Cocchiarella F; Di Agostino S; Basile V; Gostissa M; Dobbelstein M; Del Sal G; Piaggio G; Mantovani R
Mol Cell Biol; 2005 May; 25(9):3737-51. PubMed ID: 15831478
[TBL] [Abstract][Full Text] [Related]
9. The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene.
Pallai R; Simpkins H; Chen J; Parekh HK
Gene; 2010 Jul; 459(1-2):11-23. PubMed ID: 20338228
[TBL] [Abstract][Full Text] [Related]
10. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
[TBL] [Abstract][Full Text] [Related]
11. NF-Y transcriptionally regulates the Drosophila p53 gene.
Tue NT; Yoshioka Y; Yamaguchi M
Gene; 2011 Feb; 473(1):1-7. PubMed ID: 21044877
[TBL] [Abstract][Full Text] [Related]
12. Transcription repression of a CCAAT-binding transcription factor CBF/HSP70 by p53.
Chae HD; Yun J; Shin DY
Exp Mol Med; 2005 Oct; 37(5):488-91. PubMed ID: 16264274
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.
Joshi AA; Wu Z; Reed RF; Suttle DP
Mol Pharmacol; 2003 Feb; 63(2):359-67. PubMed ID: 12527807
[TBL] [Abstract][Full Text] [Related]
14. p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor.
Yun J; Chae HD; Choy HE; Chung J; Yoo HS; Han MH; Shin DY
J Biol Chem; 1999 Oct; 274(42):29677-82. PubMed ID: 10514438
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
[TBL] [Abstract][Full Text] [Related]
16. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
17. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
18. PRR11 is a novel gene implicated in cell cycle progression and lung cancer.
Ji Y; Xie M; Lan H; Zhang Y; Long Y; Weng H; Li D; Cai W; Zhu H; Niu Y; Yang Z; Zhang C; Song F; Bu Y
Int J Biochem Cell Biol; 2013 Mar; 45(3):645-56. PubMed ID: 23246489
[TBL] [Abstract][Full Text] [Related]
19. PRR11 regulates late-S to G2/M phase progression and induces premature chromatin condensation (PCC).
Zhang C; Zhang Y; Li Y; Zhu H; Wang Y; Cai W; Zhu J; Ozaki T; Bu Y
Biochem Biophys Res Commun; 2015 Mar; 458(3):501-508. PubMed ID: 25666944
[TBL] [Abstract][Full Text] [Related]
20. MDM2 negatively regulates the human telomerase RNA gene promoter.
Zhao J; Bilsland A; Jackson K; Keith WN
BMC Cancer; 2005 Jan; 5():6. PubMed ID: 15656906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
